Community Bank’s Jounce Therapeutics, Inc. Common Stock JNCE Stock Holding History

Community Bank’s Portfolio JNCE Stock Details JNCE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q2	–	Sell	-1,000	Closed	-$1.84K	–	466
2023 Q1	$1.84K	Hold	1,000	–	–	﹤0.01%	442
2022 Q4	$1.1K	Hold	1,000	–	–	﹤0.01%	463
2022 Q3	$2K	Hold	1,000	–	–	﹤0.01%	540
2022 Q2	$3K	Hold	1,000	–	–	﹤0.01%	406
2022 Q1	$7K	Hold	1,000	–	–	﹤0.01%	395
2021 Q4	$8K	Hold	1,000	–	–	﹤0.01%	395
2021 Q3	$7K	Hold	1,000	–	–	﹤0.01%	420
2021 Q2	$7K	Hold	1,000	–	–	﹤0.01%	424
2021 Q1	$10K	Sell	1,000 -1,000	-50%	-$11K	﹤0.01%	406
2020 Q4	$14K	Hold	2,000	–	–	﹤0.01%	370
2020 Q3	$16K	Hold	2,000	–	–	﹤0.01%	365
2020 Q2	$14K	Hold	2,000	–	–	﹤0.01%	364
2020 Q1	$10K	Hold	2,000	–	–	﹤0.01%	338
2019 Q4	$17K	Buy	+2,000	New	+$10.8K	﹤0.01%	336

Other funds holding JNCE

Opaleye Management Boston, Massachusetts $759M AUM 124.8% 1-Year Est. Return

Community Bank's JNCE Position: Q2 2023 in Review

Community Bank sold out of Jounce Therapeutics, Inc. Common Stock (JNCE) in Q2 2023, closing a stake of 1,000 shares — an estimated $1.84K sold.

Community Bank first reported a position in JNCE in Q4 2019 and held it in 14 quarters. The position peaked at $17K in Q4 2019. 1 fund tracked by Wall St. Rank holds JNCE as of Q2 2023.

Community Bank reported no remaining Jounce Therapeutics, Inc. Common Stock position as of Q2 2023 after selling out during the quarter.
Community Bank sold 1,000 Jounce Therapeutics, Inc. Common Stock shares in Q2 2023, an estimated $1.84K.
Community Bank first reported a position in Jounce Therapeutics, Inc. Common Stock in Q4 2019 and held it in 14 quarters.
Community Bank's Jounce Therapeutics, Inc. Common Stock position peaked at $17K in Q4 2019.
1 fund tracked by Wall St. Rank held Jounce Therapeutics, Inc. Common Stock as of Q2 2023.

Based on Community Bank's 13F filing for Q2 2023, filed 1 Aug 2023.